I
nfection with the pathogenic, soil-based fungus, Histoplasma capsulatum (Hc), 3 produces a wide spectrum of disease, ranging from a mild, influenza-like illness to a progressive, disseminated form that can be life-threatening if untreated. The extent of disease induced by Hc can be correlated to the number of fungal particles to which one is exposed. Prevention of infection from Hc requires sequestration of a contaminated area, application of toxic chemicals, and the use of respirators by workers (1) . Another means of prevention is vaccination for high risk groups. In this regard we have reported that immunization of mice with the immunodominant Ag, heat shock protein (hsp)60, from Hc confers protection against a lethal challenge given either i.v. or by intranasal (i.n.) instillation (2) . The protective effect of Hc hsp60 is contained within a domain, termed F3, that spans aa 172-443 (3).
T cells exert an extremely influential role in combating infection with this fungus. In experimental primary infection, CD4 ϩ cells are necessary for survival; CD8
ϩ cells contribute to optimal clearance (4 -7) . In the lungs of mice infected with Hc, V␤4 ϩ cells are significantly elevated during the period of infection when cellmediated immunity is activated, and depletion of this population blunts the protective immune response (8) . In secondary Hc, protective immunity is abrogated only when both CD4 ϩ and CD8 ϩ cells are eliminated. However, the protective immune response is impaired when V␤6 ϩ or V␤6 ϩ plus V␤4 ϩ cells are depleted from the host (9) .
Virtually nothing is known concerning the TCR usage to a protective Ag from this fungus or other fungi. To gain a better understanding of the cellular mechanisms associated with vaccineinduced immunity, we examined the TCR repertoire of cells that react with F3. In this way we can begin to understand the underlying mechanism(s) by which this fragment expresses protection. The results demonstrate that a very high proportion of F3-reactive monoclonal cells from immunized C57BL/6 mice are V␤6
ϩ . These cells are crucial both to the generation of Ag-reactive cells in vitro and to the protective efficacy of F3.
Materials and Methods

Mice
Five-to 6-wk-old C57BL/6 and TCR ␣␤ Ϫ/Ϫ mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Animals were housed in isolator cages and were maintained by the University of Cincinnati Department of Laboratory Animal Medicine, which is accredited by the American Association for Accreditation of Laboratory Animal Medicine. All animal experiments were performed in accordance with the Animal Welfare Act guidelines of the National Institutes of Health.
Preparation of Hc and infection of mice
Hc yeasts (strain G217B) were prepared as previously described (7) . This strain is a prototypical virulent strain of this fungus (7) . To produce a sublethal infection in naive mice, animals were infected i.n. with 2.0 ϫ 10 6 Hc yeasts in a 30-l volume. A lethal inoculum of 1.25 ϫ 10 7 yeasts was used in some experiments with immunocompetent C57BL/6 mice.
Preparation of F3
Cloning and expression of F3 have been described previously (3) . Briefly, the gene fragment was cloned into the NdeI and BamHI sites of pET19b. To express recombinant protein, Escherichia coli harboring the plasmid was grown at 37°C in Luria-Bertoni broth until an OD 600 of 0.4 -0.5 was achieved. Subsequently, isopropyl-thiogalactose was added to cultures at a final concentration of 1 mM. Cultures were continued for 3 h. Cells were harvested by centrifugation at 5000 ϫ g. The pellet was suspended in a buffer consisting of 5 mM imidazole, 500 mM NaCl, and 20 mM Tris-HCl, pH 7.9, and was lysed by freeze-thaw cycles followed by sonification. Soluble and insoluble fractions were separated by centrifugation at 20,000 ϫ g. Received for publication January 31, 2001 . Accepted for publication June 7, 2001 .
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The insoluble pellet was suspended in a buffer consisting of 6 M urea, 500 mM NaCl, 5 mM imidazole, and 20 mM Tris-HCl, pH 7.9. The denatured material was recovered in supernatants after centrifugation at 20,000 ϫ g and then filtered to remove particulate material. The protein was purified by metal chelate chromatography using Ni 2ϩ -Sepharose affinity column (His-Bind; Novagen, Madison, WI). The recombinant protein was eluted with the same buffer as described above, except that it contained 1 M imidazole. The eluate was dialyzed against buffer containing decreasing amounts of urea. The eluate was concentrated by ultrafiltration, and protein concentration was determined. F3 contained Ͻ10 pg LPS/g protein.
Organ culture for Hc
Recovery of Hc was performed as previously described (7) . Fungal burden was expressed as mean CFU per whole organ Ϯ SEM. The limit of detection is 10 2 CFU.
Preparation of mAb
Rat anti-mouse V␤6 chain (rat IgG2b, clone RR4-7) was provided by Dr. Osami Kanagawa (Washington University, St. Louis, MO). Rat anti-mouse V␤7 (rat IgG2b, clone TR 310) was provided by Dr. Irving Weissman (Stanford University, Stanford, CA). Ascites was prepared in nude mice. The IgG fraction was purified using a protein G-agarose column (Amersham-Pharmacia, Piscataway, NJ). The concentration of mAb was determined by ELISA using rat IgG as standard.
Immunization
Mice were immunized s.c. with F3 or, as a control, BSA. Both Ag were suspended in adjuvant containing monophosphoryl lipid A, synthetic trehalose dicorynomycolate, and cell wall skeleton (Ribi Immunochem, Hamilton, MT) at a concentration of 1 mg/ml. Animals were injected s.c. with 0.1 ml emulsion (100 g protein) twice. Injections were separated by 2 wk, and mice were infected 2 wk after the last immunization.
Splenocyte preparation
Spleen cells were isolated by teasing apart spleens between the frosted ends of two ground glass slides. Cells were washed three times in HBSS and resuspended in RPMI 1640 containing 10% FBS, 1% nonessential amino acids, 1% sodium pyruvate, 5 ϫ 10 Ϫ5 M 2-ME, and 10 g/ml gentamicin (complete medium) if the cells were to be used for the establishment of T cell lines. For adoptive transfer experiments, cells were suspended in HBSS.
Isolation of lung leukocytes
Lungs were excised after flushing circulating leukocytes by injecting of 3 ml HBSS into the right ventricle. Lungs were minced apart in 10 ml of RPMI, and a single-cell suspension was obtained by forcing the lung fragments through needles of progressively smaller gauge, followed by filtration through a 60-m nylon mesh. Leukocytes were purified by a 600 ϫ g centrifugation through a discontinuous 40/70% Percoll gradient and were enumerated with a hemocytometer.
Establishment of T cell lines and clones
T cell lines and clones were initiated and maintained as previously described (10) . T cells were propagated in the presence of irradiated splenocytes (2.0 ϫ 10 6 ), 20 g/ml F3 or 125 g/ml OVA (for the OVA-reactive clone SOG), and 5% IL-2 enriched supernatant. The source of IL-2 was produced by stimulating Lewis rat splenocytes with 5 g/ml Con A for 48 h. Supernatants were harvested and 20 mg/ml ␣-methyl-mannoside/ml was added. This preparation was filter-sterilized and stored at Ϫ70°C.
Proliferation assays
Resting T cells were suspended in RPMI 1640 supplemented with 10% FBS and 10 g/ml gentamicin. To each well of a microtiter plate were added 2 ϫ 10 4 T cells in 0.1 ml, 5 ϫ 10 5 irradiated splenocytes in 0.1 ml, and 50 l F3 (the final concentration in a well was 20 g/ml). Cells were incubated for 72 h; 16 h before cell harvest, 1 Ci [ 3 H]thymidine (sp. act., 6.7 Ci/mmol; New England Nuclear, Boston, MA) was added to each culture. Cells were collected on glass-fiber filters with a semiautomated harvester, and uptake of radioactivity was measured by a liquid scintillation counter. The stimulation index equals the cpm of cells in response to Ag minus the cpm of cells in medium alone.
RNA extraction
Cells (1 ϫ 10 6 ) were incubated in 0.2 ml RNAzol (Biotecx Laboratories, Houston, TX). RNA was extracted with chloroform and precipitated following the manufacturer's protocol. RNA was resuspended in nucleasefree water, and the nucleic acid yield and purity were determined by OD 260 and the OD 260 /OD 280 ratio. Samples were kept at Ϫ70°C until processed.
RT-PCR of V␤ families
One microgram of total RNA was annealed with 10 ng of an antisense primer complementary to the constant region of the ␤-chain (C␤1) of TCR. First-strand cDNA synthesis was performed with avian myeloblastosis virus reverse transcriptase (Promega, Madison, WI) and dNTPs. Aliquots of 1 l of the RT reaction were used as template in 20 parallel PCR. Each tube contained a common nested antisense primer specific to the constant region of the ␤-chain (C␤2) and each of 20 V␤-specific sense primers (9), dNTPs, and Taq polymerase (Life Technologies, Gaithersburg, MD). Reactions were denatured at 94°C for 45 s, annealed at 60°C for 45 s, and extended at 72°C for 60 s. The number of cycles necessary to produce a visible signal without saturation was determined in preliminary experiments. Between 28 and 32 cycles were used for most samples. The primers and their sequences have been previously published (11) .
The presence of a V␤-specific PCR product was determined by Southern blot: 5 l of each PCR was electrophoresed in 1% agarose gels, blotted onto nylon membranes (Roche, Indianapolis, IN), and hybridized with a digoxigenin-labeled DNA probe specific to the C␤ region of the TCR. After washing in 0.1% SSC at 65°C, the signal was revealed with alkaline phosphatase-conjugated anti-digoxigenin Fab (GENIUS system; Roche) and the chemiluminescence substrate CDP Star (Roche). Light production was measured directly with a ChemiImager 4000 instrument (Alpha Innotech, San Leandro, CA).
Sequencing the TCR
The PCR product from V␤6 ϩ or V␤14 ϩ cells was cloned into pCR2.1 TOPO TA and transformed in TOP10FЈ cells (Invitrogen, Carlsbad, CA). For each T cell clone, plasmids from at least three colonies were sequenced.
FACS analysis
Cells were adjusted to 5 ϫ 10 5 /200 l in PBS containing 2% BSA and 0.02% sodium azide and stained with 0.5 g of one of the following FITClabeled mAbs (PharMingen, San Diego, CA): anti-CD4 (clone RM4-5), anti-CD8 (clone 53-6.7), or biotin-conjugated anti-V␤6 (clone RR4-7) or anti-V␤14 (clone 14-2), followed by incubation with streptavidin-PE . To determine the percentage of cells expressing V␤6 or V␤14 following adoptive transfer into TCR ␣␤ Ϫ/Ϫ mice, lung leukocytes and splenocytes were adjusted to 5 ϫ 10 5 /200 l in PBS containing 2% BSA and 0.02% sodium azide and stained with allophycocyanin-conjugated anti-CD3 (clone 145-2C11) or with biotin-conjugated anti-V␤6 or anti-V␤14, followed by incubation with streptavidin-PE. Staining with isotype-matched rat IgG or IgM mAb was performed in parallel. The samples were washed and fixed in 2% paraformaldehyde until analyzed on a flow cytometer.
In vivo depletion
Groups of mice were depleted of V␤6 ϩ or V␤7 ϩ T cells by injection of 150 g RR4-7 or an equal amount of TR-310 mAb i.p. on days -7 and -3 and on the day of immunization. Mice were injected with mAb once a week thereafter until the end of each experiment. Control mice were given an equal amount of rat IgG i.p. The efficiency of depletion was Ͼ95% as determined by flow cytometry.
Adoptive transfer
Splenocytes were suspended in HBSS and injected i.v. into mice 8 h before i.n. infection. With splenocytes, 2 ϫ 10 7 cells/recipient were injected; for T cell clones, 2 ϫ 10 6 /recipient were injected.
Generation of cytokine-containing supernatants
Splenocytes from F3-immunized mice treated with mAb to V␤6 or with rat IgG were resuspended in complete medium at a concentration of 3 ϫ 10 6 /ml. One milliliter of cells was added to each well of a 24-well plate, and cells were incubated in the presence or absence of F3 (20 g/ml). To generate supernatants from T cell clones, 10 5 T cells were incubated with 2.0 ϫ 10 6 irradiated splenocytes in the presence or the absence of 20 g/ml F3. One milliliter of cells was dispensed into each well of 24-well plate. All cultures were incubated for 48 h at 37°C in 5% CO 2 . Supernatants were harvested, filter-sterilized, and stored at Ϫ70°C until assayed.
Cytokine analysis
Commercially available ELISA kits were used to measure IFN-␥, IL-4, TNF-␤, GM-CSF (Endogen, Cambridge, MA), and IL-10 (PharMingen, San Diego, CA). The data for cytokine measurement were expressed as the ⌬ cytokine by subtracting the amount of cytokine detected in medium alone from that found in supernatants of Ag-stimulated cells.
Statistics
Student's t test was used to compare groups if the data achieved normality; otherwise, the Wilcoxon rank-sum test was used. Survival data were analyzed using the log-rank test.
Results
TCR usage of F3-reactive clones
Groups of mice were immunized with F3, and T cell lines were established by propagation in fresh medium, Ag, and a source of IL-2 every 2 wk. After 6 passages the lines were cloned at 1 and 0.3 cells/well. All positive wells were expanded and assessed for reactivity. Eighteen clones that reacted with F3 from 2 independent lines were isolated and analyzed for V␤ expression by RT-PCR and Southern blot. Among the 18 clones, 15 expressed V␤6 and three expressed V␤14 (Table I) . V␤ expression was confirmed by FACS analysis. All clones were CD4
ϩ .
CDR3 and J␤ sequence of the F3-reactive clones
The sequences of the CDR3 and J␤ regions were determined by PCR amplification of cDNA using a V␤6 sense primer combined with a C␤ antisense primer. The resulting bands were gel-purified, cloned, and transformed into E. coli. Several colonies from each T cell clone were sequenced in both directions. Analysis of the clones indicated that six of 15 V␤6 ϩ T cell clones expressed J␤2.3, four expressed J␤2.2, three expressed J␤2.6, and two expressed J␤1.3. All three of the V␤14 ϩ clones expressed J␤2.4 (Table I ). The amino acid composition of the CDR3 region from V␤6 ϩ clones revealed the motif of IxGGG or IGG. The motif of SFSGG was found for each of the V␤14 ϩ clones (Table I) .
TCR usage and elimination of V␤6 ϩ cells in F3-immunized mice
We sought to determine whether elimination of V␤6 ϩ cells from F3-immunized mice would alter V␤ expression by F3-reactive clones. Mice were depleted of V␤6 ϩ cells by treatment with mAb to it and were immunized with F3. In six independent attempts we were unable to establish T cell lines that could be propagated longer than 1 month. Moreover, in proliferation assays the shortterm lines from mice lacking V␤6 ϩ cells failed to proliferate in response to F3. The stimulation index never exceeded 1 at each concentration of Ag tested (1-250 g/ml). As an example, the mean response (ϮSEM) by splenocytes from F3-immunized mice that lacked V␤6 ϩ cells in the presence of 20 g/ml F3 was 12,028 Ϯ 1,129 cpm, and in the absence of Ag the response was 12,778 Ϯ 766 cpm. In contrast, the mean response by one of the F3-reactive lines to F3 was 16,486 Ϯ 409 cpm, whereas the response by cells in medium alone was 2,618 Ϯ 906 cpm.
To determine whether elimination of any V␤ family would alter the ability to establish F3-reactive clones or affect the TCR usage, we depleted mice of V␤7 ϩ cells and immunized with F3. T cell clones were isolated from V␤7 ϩ cell-depleted mice. Ten F3-reactive clones were analyzed for V␤ expression. All 10 clones were V␤6 ϩ , and nine expressed the J␤ 2.2 sequence, whereas one was J␤1.2. The amino acid sequence of the CDR3 was SHAGG or SPSGG for the J␤2.2 ϩ clones and RDN for the J␤ 1.2 ϩ clone (Table II) .
In vivo effect of V␤6 ϩ cells in F3-immunized animals
Because V␤6 ϩ cells were central in establishing T cell reactivity to F3, we endeavored to determine whether their presence was essential for host protection following F3 immunization. Mice were treated with mAb to V␤6 or rat IgG and injected s.c. with F3. Two weeks after immunization, mice were challenged with 2 ϫ 10 6 Hc yeasts. One week later, mice were sacrificed, and the fungal burden in lungs and spleens was determined. These organs from mice immunized with F3 contained significantly fewer ( p Ͻ 0.01) CFU than controls. Depletion of V␤6 ϩ cells abrogated the protective efficacy of F3 in both lungs and spleens (Fig. 1, A and B) . In a separate set of studies, mice were given mAb to V␤7 and immunized with F3. Elimination of V␤7 ϩ cells did not abrogate the protective efficacy of F3. Both groups of F3-immunized mice contained significantly fewer ( p Ͻ 0.01) CFU in lungs and spleens compared with controls (Fig. 1, C and D) .
Subsequently, we examined whether elimination of V␤6 ϩ cells altered the protective efficacy in mice given a lethal challenge of Hc (1.25 ϫ 10 7 yeasts i.n.). As an additional control, a group of F3-immunized mice was depleted of V␤7 ϩ cells. All F3-immunized mice that lacked the V␤6 family and controls succumbed to infection with a similar time course (Fig. 1E) . In contrast, 83% of F3-immunized mice treated with rat IgG and 75% of immunized mice given mAb to V␤7 survived for 40 days (Fig. 1E) . The results Table I . b CDR3; see Table I. for the F3-immunized mice given rat IgG or mAb to V␤7 differed significantly ( p Ͻ 0.01) from those of F3-immunized mice lacking V␤6 ϩ cells or from unimmunized controls. The survival profile of F3-immunized mice treated with rat IgG was similar ( p Ͼ 0.05) to that of immunized recipients of mAb to V␤7. At the termination of the experiment, the surviving mice were sacrificed, and lungs and spleens were assayed for the presence of Hc. From each animal the number of CFU in lungs and spleens was below the limits of detection (10 2 CFU). One explanation for the effect of the elimination of V␤6 ϩ cells is that this family is pivotal for host defenses to Hc even in unimmunized mice. To address this issue, naive C57BL/6 mice were administered mAb to V␤6 or rat IgG and then infected i.n. with 2 ϫ 10 6 Hc yeasts. At wk 1 of infection, fungal recovery (mean log 10 CFU Ϯ SEM) in lungs (6.60 Ϯ 0.01 CFU) and spleens (4.95 Ϯ 0.11 CFU) did not differ significantly ( p Ͼ 0.05) from that in lungs (6.85 Ϯ 0.06 CFU) and spleens (5.21 Ϯ 0.08 CFU) of mice depleted of V␤6 ϩ cells.
Adoptive transfer of protective cells from immunized mice
Once we established that V␤6 ϩ cells were crucial for generation of an F3-reactive T cell line and for vaccine efficacy in vivo, a series of experiments was conducted to determine whether cells from F3-immunized mice could adoptively transfer protection into immunodeficient mice. Mice lacking TCR ␣␤ ϩ cells were selected as recipients for evaluating the protective efficacy of adoptively transferred cells because they are susceptible to Hc, and T cells may repopulate their organs.
Splenocytes from F3-and BSA-immunized mice were harvested and stimulated in vitro with 20 g/ml of Ag for 5 days, and cells were transferred to TCR ␣␤ Ϫ/Ϫ mice that were infected i.n. 8 h later. As an additional control, a group of TCR ␣␤ Ϫ/Ϫ mice received no cells. Transfer of the splenocytes from F3-immunized, but not BSA-immunized, mice reduced ( p Ͻ 0.01) the fungal burden at wk 1 of infection (Fig. 2, A and B) and improved survival ( p Ͻ 0.01; Fig. 2C ). At the termination of the study the recipients of F3-stimulated splenocytes were sacrificed, and lungs and 
Elimination of V␤6 ϩ cells from F3-immunized mice abrogates the protective activity of adoptively transferred cells
Mice were given rat IgG or mAb to V␤6 beginning 1 wk before vaccination with F3. Treatment with Ab was continued throughout the period of vaccination and extended for 2 wk after the last injection of F3. At that time spleen cells were harvested and stimulated with F3 for 5 days, and cells were injected i.v. into TCR ␣␤ Ϫ/Ϫ mice (2 ϫ 10 7 splenocytes/mouse). Eight hours later mice were infected i.n. with Hc yeasts. At 1 wk of infection, the lungs and spleens of mice were examined for fungal burden. The organs of TCR ␣␤ Ϫ/Ϫ mice that received F3-stimulated splenocytes contained significantly fewer CFU ( p Ͻ 0.01) than those of mice that received no cells. Elimination of V␤6 ϩ cells reversed the capacity of F3-stimulated splenocytes to mediate protection (Fig. 3, A and  B) . Transfer of splenocytes from F3-immunized mice promoted the survival of TCR ␣␤ Ϫ/Ϫ mice, whereas cells from V␤6 ϩ -depleted mice did not (Fig. 3C) . The surviving mice were sacrificed, and CFU in lungs and spleens was assessed. The mean log 10 CFU was Ͻ10 3 in both lungs and spleens.
A V␤6 ϩ T cell clone confers protection in TCR ␣␤ Ϫ/Ϫ mice
The T cell clone 9.14, which expresses V␤6, was injected i.v. into TCR ␣␤ Ϫ/Ϫ mice 8 h before i.n. challenge with Hc. Separate sets of mice received no cells; SOG, an OVA-reactive clone; or clone 2.6, a clone that expresses V␤14. Mice that did not receive cells and mice that received SOG or 2.6 all died by day 17 (Fig. 4) . In contrast, 60% of recipients of 9.14 survived for 40 days ( p Ͻ 0.01). After 40 days, the remaining mice were sacrificed, and the fungal burden in lungs and spleens was quantified. Both sets of organs contained Ͻ10 3 CFU. (Table III) . On day 7 postinfection the number and percentage of CD3 ϩ V␤6 ϩ cells in lungs and spleens were higher than those of CD3 ϩ V␤14 ϩ , but the data failed to reach statistical significance ( p Ͼ 0.05; Table III ). The data also indicate that between days 3 and 7 of infection there was expansion of each clonal population within lungs and spleens of mice.
Cytokine analysis of cells
Because the elimination of V␤6
ϩ cells abrogated the protective immune response induced by F3, we sought to determine whether cytokine production was modulated by depletion of these cells. Four weeks after immunization with F3, splenocytes from mice that were treated with mAb to V␤6 or with rat IgG were stimulated in vitro with F3, and supernatants were harvested. Splenocytes from mice devoid of V␤6 ϩ cells produced similar amounts ( p Ͼ 0.05) of IFN-␥, TNF-␤, GM-CSF, IL-4, and IL-10 compared with mice given rat IgG.
Additional studies examined the cytokine production by clones 2.6 (V␤14 ϩ ) and 9.14 (V␤6 ϩ ). Clone 9.14 released substantially more IFN-␥, TNF-␤, and GM-CSF than clone 2.6 (Table IV) . Production of IL-4 was negligible from both lines, and IL-10 generation was similar (Table IV) . Analysis of six other V␤6 ϩ clones revealed a cytokine profile similar to that of 9.14 (data not shown). yeast cells i.n. At wk 1 of infection, a group of mice (n ϭ 6 -7) was sacrificed, and CFU were enumerated in lungs (A) and spleens (B) of mice. Data are the mean Ϯ SEM. In addition, mice (n ϭ 6 -7) were followed for survival (C). ‫,ء‬ p Ͻ 0.01.
Discussion
Vaccination with the protective domain of hsp60 from Hc induced a dramatic skewing in the V␤ repertoire. The vast majority of F3-reactive T cell clones expressed V␤6 with a limited J␤ usage and a conserved CDR3 region. Neither J␤ usage nor the CDR3 sequence could be correlated with the vigor of the proliferative response to F3. Furthermore, not only was the V␤6 ϩ population critically important in the propagation of T cell clones, but it was pivotal in mediating host protection induced by F3. The capacity of V␤6 ϩ cells to support T cell clone growth was intertwined with the ability of this cell population to express protective activity.
Accumulated evidence has documented clonal or oligoclonal expansion of V␤ families in experimental models of infection and autoimmunity (12) (13) (14) (15) (16) . Likewise, limited heterogeneity in TCR usage has been demonstrated in humans with some infectious diseases (17, 18) , multiple sclerosis (19) , and obliterative bronchioloitis associated with lung transplantation (20) . In a high proportion of studies performed during experimental infection, associations have been established between disease and TCR bias, but little is known about the role of the expanded V␤ family in disease recovery or exacerbation. One prominent example has been a model of cutaneous leishmaniasis in which the same TCR family (V␣8-V␤4) emerges in both susceptible and resistant mice (12) . These results strongly suggest that the same T cell family contributes to clearance or progression of the pathogen depending on the genetic background of the host.
The predominance of V␤6 ϩ T cell clones provided an impetus to analyze clonal usage in F3-immunized mice that were depleted of V␤6 ϩ cells. We postulated that V␤14 ϩ T cell clones would emerge from these mice, because this family was detected in F3-immunized animals. Multiple attempts to generate clones from V␤6 ϩ cell-depleted mice failed. The inability of V␤6 ϩ cell-depleted mice to generate T cell clones was associated with a nonexistent response to F3. Similarly, mAb-mediated elimination in DBA/2 mice of the dominant TCR family, V␤8.2 ϩ cells, that responds to peptide 110 -121 from sperm whale myoglobin results in a weak in vitro response to Ag by cells from these mice (21) . In both experimental systems a single V␤ family was the key to Ag responsiveness.
We recently reported that in the lungs of C57BL/6 mice with secondary histoplasmosis, the V␤6 ϩ cell is the only V␤ family to undergo expansion (9) . This population is significantly elevated on days 7, 10, and 14 of infection and declines thereafter. Depletion of these cells exacerbates the course of pulmonary Hc (9) . The pivotal contribution of this cell population raised the possibility that an epitope from F3 may have driven the expansion of V␤6 ϩ clone (9.14) and then inoculated with 2.0 ϫ 10 6 yeasts i.n. 8 h later. Mice (n ϭ 5) were followed for survival.
FIGURE 3. Elimination of V␤6
ϩ cells abrogates the capacity of splenocytes from F3-immunized mice to mediate protection. Spleen cells from mice administered mAb to V␤6 or rat IgG and immunized with F3 were stimulated in vitro with 20 g/ml Ag for 4 days. Cells were harvested, and 2 ϫ 10 7 were injected i.v. into TCR ␣␤ Ϫ/Ϫ mice. Eight hours later mice were infected with 2.0 ϫ 10 6 yeasts i.n. At wk 1 of infection a group of mice (n ϭ 6 -7) was sacrificed, and CFU were enumerated in lungs (A) and spleens (B) of mice. Data are the mean Ϯ SEM. In addition, mice (n ϭ 6 -7) were followed for survival (C). ‫,ء‬ p Ͻ 0.01.
CDR3 sequences found in the F3-derived clones and the V␤6 ϩ cells from the lungs of mice with secondary infection reveal no overriding similarities. It is unlikely that the V␤6 ϩ family from the lungs of infected mice is recognizing the same Ag.
The finding that only two V␤ families were detected among 28 F3-reactive clones was unexpected, because we had postulated that TCR usage would be more diverse given the relatively large size of the polypeptide. The preferential usage of J␤ families and CDR3 expression in conjunction with the outgrowth of a fairly limited set of V␤ families strongly suggests that the response is driven by a peptide or, at the very least, a limited set of peptides. Identification of the peptide(s) from this protein that drives the expansion of V␤6 and/or V␤14 families is underway.
Insight into the functional role of V␤6 ϩ cells in vaccine-induced immunity was accomplished in two different sets of experiments.
Elimination of V␤6
ϩ cells reversed the protective activity of F3 in intact mice. In contrast, V␤6 ϩ cells were dispensable for primary infection of mice. Thus, the remaining T cells from F3-immunized mice that were depleted of V␤6 ϩ cells failed to compensate for the abolished population.
We complemented the above experiments with a companion set of studies that sought to determine whether V␤6 ϩ cells were necessary for protection by adoptive transfer. Splenocytes from mice immunized with F3 and treated with mAb to V␤6 did not transfer protection in TCR ␣␤ Ϫ/Ϫ mice, as measured by a reduction in CFU and survival. To validate this finding, transfer of a V␤6
ϩ , but not V␤14 ϩ , T cell clone conferred protection despite the similarity in the CDR3 sequence between the two clones. The results indicate that V␤6 ϩ cells are critical in vaccine-induced immunity. One concern in using T cell clones is that they may not traffic normally in an intact host (21, 22) . The likely mechanism is that these cells do not express CD62L (MEL-14 or L-selectin), which is required for lymphocyte homing to peripheral lymphoid organs (23, 24) . To determine whether the protective efficacy of the V␤6 ϩ clone was a result of improved survival within the host, we examined the lungs and spleens of Hc-infected TCR ␣␤ Ϫ/Ϫ mice for the presence of V␤6 ϩ or V␤14 ϩ cells. Interestingly, the percentage and number of V␤6 ϩ cells in each organ exceeded those of V␤14 ϩ cells, and the differences were statistically significant on day 3 postinfection. Hence, the protective effect exerted by CD3 ϩ V␤6 ϩ cells may be explained in part by the elevated numbers of this population found in lungs and spleens during the early phase of infection (Յ3 days).
In experimental infection with viable Hc yeasts, IFN-␥, TNF-␤, and GM-CSF are critical for effective host resistance to this fungus (6, 7, (25) (26) (27) (28) (29) (30) (31) . By contrast, IL-4 and IL-10 antagonize host defenses (25, 26, 31) . We sought to determine whether the ineffectiveness of cells from F3-immunized mice administered mAb to V␤6 to confer protection was associated with alterations in cytokine generation. Splenocytes from V␤6 ϩ cell-depleted mice immunized with F3 produced nearly equal amounts of cytokines as cells from immunized mice with V␤6 ϩ cells, but the former did not proliferate in response to Ag. The dissociation between cytokine production and inability to proliferate was unexpected. Others (32, 33) have reported that proliferation and cytokine release are not inextricably connected. The most likely explanation is that the TCR signaling necessary for proliferation differs from that necessary for cytokine generation. We could not discriminate between the two populations of cells by in vitro generation of cytokines that are known to influence the course of infection with Hc. Hence, it is possible that another cytokine or chemokine that potentially contributes to host resistance is released only by V␤6 ϩ cells. When cytokine production by T cell clones was analyzed, there was a correlation between protective efficacy and release of cytokines that augment host resistance. Collectively, these findings indicate that the protective efficacy of unfractionated spleen cells may be more dependent on the ability to undergo clonal expansion. At the clonal level, cytokine production discriminated between a protective and a nonprotective clone. In summary, we have demonstrated a pronounced bias in the TCR repertoire to a protective immunogen from the pathogenic fungus, Hc. V␤6 ϩ cells were instrumental in proliferation to this Ag as well as in protective efficacy. These results demonstrate that a single V␤ family may be requisite for successful vaccination to a polypeptide.
